ATC Group: D05AX04 Tacalcitol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D05AX04 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D05 Antipsoriatics
3 D05A Antipsoriatics for topical use
4 D05AX Other antipsoriatics for topical use
5 D05AX04 Tacalcitol

Active ingredients in D05AX04

Active Ingredient Description
Tacalcitol

Tacalcitol is a vitamin D3 derivative, which inhibits keratinocyte hyper-proliferation and induces differentiation of these cells. The normalisation of these mechanisms is the basis for the efficacy in the treatment of psoriasis.

Related product monographs

Title Information Source Document Type  
CURATODERM Ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Japan (JP)

Poland (PL)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.